{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:53:28Z","timestamp":1761504808604,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.yebeh.2022.108668","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T12:27:00Z","timestamp":1650889620000},"page":"108668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PA","title":["Quality of life in patients with symptomatic epilepsy due to neurocysticercosis"],"prefix":"10.1016","volume":"131","author":[{"given":"Willy R.","family":"Zapata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier A.","family":"Bustos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Javier","family":"Pretell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector H.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108668_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/159821","article-title":"Neurocysticercosis: a review","volume":"2012","author":"Del Brutto","year":"2012","journal-title":"Sci World J"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108668_b0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/CON.0000000000000986","article-title":"Parasitic infections of the nervous system","volume":"27","author":"Garcia","year":"2021","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2022.108668_b0015","first-page":"197","article-title":"Current diagnostic criteria for neurocysticercosis","volume":"12","author":"Guzman","year":"2021","journal-title":"Res Rep Trop Med"},{"key":"10.1016\/j.yebeh.2022.108668_b0020","first-page":"1160","article-title":"1991\u20131994","volume":"42","author":"Summeijer","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0025","first-page":"58","article-title":"Factors associated with impaired quality of life in younger and older adults with epilepsy","volume":"83","author":"Canuet","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4269\/ajtmh.2011.10-0646","article-title":"Quality of life in patients with neurocysticercosis in Mexico","volume":"84","author":"Flisser","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.yebeh.2022.108668_b0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s10900-010-9351-5","article-title":"Quality of life assessment in patients with neurocysticercosis","volume":"36","author":"de Almeida","year":"2011","journal-title":"J Community Health"},{"key":"10.1016\/j.yebeh.2022.108668_b0040","doi-asserted-by":"crossref","unstructured":"Wallin MT, Pretell EJ, Bustos JA, Caballero M, Alfaro M, et al. (2012) Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLOS Negl Trop Dis 6(1): e1493. https:\/\/doi.org\/10.1371\/journal.pntd.0001493.","DOI":"10.1371\/journal.pntd.0001493"},{"key":"10.1016\/j.yebeh.2022.108668_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2016.09.032","article-title":"Quality of life in epilepsy-31 inventory (QOLIE-31) scores: a global comparison","volume":"65","author":"Saadi","year":"2016","journal-title":"Epilepsy Behav: E&B"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108668_b0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","article-title":"Cysticercosis Working Group in Peru. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis","volume":"72","author":"Garcia","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108668_b0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(14)70779-0","article-title":"Cysticercosis Working Group in Peru. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial","volume":"14","author":"Garcia","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108668_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108668_b0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5152\/npa.2015.8727","article-title":"Validity and reliability of the Quality of Life in Epilepsy Inventory (QOLIE-31) for Turkey","volume":"52","author":"Mollao\u011flu","year":"2015","journal-title":"Noro psikiyatri arsivi"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108668_b0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/ebeh.2001.0170","article-title":"Psychometric properties of the German translation of the QOLIE-31","volume":"2","author":"May","year":"2001","journal-title":"Epilepsy Behav: E&B"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108668_b0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yebeh.2011.12.023","article-title":"Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures","volume":"23","author":"Borghs","year":"2012","journal-title":"Epilepsy Behav: E&B"},{"key":"10.1016\/j.yebeh.2022.108668_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.seizure.2006.10.011","article-title":"Factors influencing on quality of life in people with epilepsy","volume":"16","author":"Guekht","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.108668_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0028-3886.15054","article-title":"frequent seizures and polytherapy can impair quality of life in persons with epilepsy","volume":"53","author":"Thomas","year":"2005","journal-title":"Neurology India"},{"key":"10.1016\/j.yebeh.2022.108668_b0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1528-1157.2002.32201.x","article-title":"Seizure reduction and quality of life improvements in people with epilepsy","volume":"43","author":"Birbeck","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0095","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1528-1167.2009.02165.x","article-title":"Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy","volume":"50","author":"Lacey","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0100","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","article-title":"Determinants of health - related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments","volume":"52","author":"Luoni","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0110","doi-asserted-by":"crossref","unstructured":"Herrick, J. A., Bustos, J. A., Clapham, P., Garc\u00eda, H. H., Loeb, J. A., & for the Cysticercosis Working group in Peru. (2020). Unique characteristics of epilepsy development in neurocysticercosis, Am J Trop Med Hygiene, 103 (2), 639-645. Retrieved Oct 7, 2021 from https:\/\/www.ajtmh.org\/view\/journal\/tpmd\/103\/2\/article-p639.xml.","DOI":"10.4269\/ajtmh.19-0485"},{"key":"10.1016\/j.yebeh.2022.108668_b0115","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s00415-017-8512-1","article-title":"Characteristics associated with quality of life among people with drug \u2013 resistant epilepsy","volume":"264","author":"Ridsdale","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2022.108668_b0120","first-page":"244","article-title":"Study of quality of life and prognostic factors of patients with refractory epilepsy of Essalud\u2019s Miguel Grau Hospital, Lima \u2013 Peru","volume":"27","author":"Perez","year":"2010","journal-title":"Acta Med Per"},{"key":"10.1016\/j.yebeh.2022.108668_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2008.09.027","article-title":"Quality of life in seizure-free patients with epilepsy on monotherapy","author":"Auriel","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108668_b0130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11136-008-9375-9","article-title":"Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece","volume":"17","author":"Piperidou","year":"2008","journal-title":"Qual Life Res"},{"key":"10.1016\/j.yebeh.2022.108668_b0135","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/epi.13130","article-title":"Neurocysticercosis: An uncommon cause of drug-refractory epilepsy in North Indian population","volume":"56","author":"Goyal","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108668_b0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.108668_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-12-49","article-title":"Health - related quality of life in epilepsy patients receiving antiepileptic drugs at National Referral Hospitals in Uganda: a cross - sectional study","volume":"12","author":"Nabukenya","year":"2014","journal-title":"Health Quality Life Outcomes"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022001172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022001172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:46:04Z","timestamp":1761504364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S1525505022001172"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108668","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life in patients with symptomatic epilepsy due to neurocysticercosis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108668"}}